vs
Side-by-side financial comparison of Boeing (BA) and NEOGENOMICS INC (NEO). Click either name above to swap in a different company.
Boeing is the larger business by last-quarter revenue ($22.2B vs $190.2M, roughly 116.8× NEOGENOMICS INC). On growth, Boeing posted the faster year-over-year revenue change (14.0% vs 10.6%). NEOGENOMICS INC produced more free cash flow last quarter ($-6.5M vs $-1.5B). Over the past eight quarters, Boeing's revenue compounded faster (14.8% CAGR vs 10.3%).
The Boeing Company is an American multinational corporation that designs, manufactures, and sells airplanes, rotorcraft, rockets, satellites, and missiles worldwide. The company also provides leasing and product support services. Boeing is among the largest global aerospace manufacturers; it is the fourth-largest defense contractor in the world based on 2022 revenue and is the largest exporter in the United States by dollar value. Boeing was founded in 1916 by William E.
NeoGenomics Laboratories, Inc., also known as NeoGenomics or Neo, is an American CLIA-certified clinical laboratory, pharma services and information services company that specializes in cancer genetics diagnostic testing. The company's testing services include cytogenetics, fluorescence in situ hybridization (FISH), flow cytometry, immunohistochemistry, anatomic pathology, and molecular genetics.
BA vs NEO — Head-to-Head
Income Statement — Q1 2026 vs Q4 2025
| Metric | | |
|---|---|---|
| Revenue | $22.2B | $190.2M |
| Net Profit | $-7.0M | — |
| Gross Margin | — | 43.8% |
| Operating Margin | 2.0% | -7.1% |
| Net Margin | -0.0% | — |
| Revenue YoY | 14.0% | 10.6% |
| Net Profit YoY | 77.4% | — |
| EPS (diluted) | $-0.11 | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $22.2B | — | ||
| Q4 25 | $23.9B | $190.2M | ||
| Q3 25 | $23.3B | $187.8M | ||
| Q2 25 | $22.7B | $181.3M | ||
| Q1 25 | $19.5B | $168.0M | ||
| Q4 24 | $15.2B | $172.0M | ||
| Q3 24 | $17.8B | $167.8M | ||
| Q2 24 | $16.9B | $164.5M |
| Q1 26 | $-7.0M | — | ||
| Q4 25 | $8.2B | — | ||
| Q3 25 | $-5.3B | $-27.1M | ||
| Q2 25 | $-611.0M | $-45.1M | ||
| Q1 25 | $-37.0M | $-25.9M | ||
| Q4 24 | $-3.9B | — | ||
| Q3 24 | $-6.2B | $-17.7M | ||
| Q2 24 | $-1.4B | $-18.6M |
| Q1 26 | — | — | ||
| Q4 25 | 7.6% | 43.8% | ||
| Q3 25 | -10.2% | 42.8% | ||
| Q2 25 | 10.7% | 42.6% | ||
| Q1 25 | 12.4% | 43.6% | ||
| Q4 24 | -10.4% | 44.9% | ||
| Q3 24 | -19.7% | 44.6% | ||
| Q2 24 | 7.3% | 44.1% |
| Q1 26 | 2.0% | — | ||
| Q4 25 | 36.7% | -7.1% | ||
| Q3 25 | -20.5% | -14.4% | ||
| Q2 25 | -0.8% | -26.3% | ||
| Q1 25 | 2.4% | -16.6% | ||
| Q4 24 | -24.7% | -10.7% | ||
| Q3 24 | -32.3% | -12.6% | ||
| Q2 24 | -6.5% | -13.3% |
| Q1 26 | -0.0% | — | ||
| Q4 25 | 34.3% | — | ||
| Q3 25 | -22.9% | -14.4% | ||
| Q2 25 | -2.7% | -24.9% | ||
| Q1 25 | -0.2% | -15.4% | ||
| Q4 24 | -25.4% | — | ||
| Q3 24 | -34.6% | -10.5% | ||
| Q2 24 | -8.5% | -11.3% |
| Q1 26 | $-0.11 | — | ||
| Q4 25 | $10.70 | — | ||
| Q3 25 | $-7.14 | — | ||
| Q2 25 | $-0.92 | — | ||
| Q1 25 | $-0.16 | — | ||
| Q4 24 | $-5.50 | — | ||
| Q3 24 | $-9.97 | — | ||
| Q2 24 | $-2.33 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $9.4B | $159.6M |
| Total DebtLower is stronger | $44.4B | $341.9M |
| Stockholders' EquityBook value | $6.0B | $836.6M |
| Total Assets | $164.8B | $1.4B |
| Debt / EquityLower = less leverage | 7.41× | 0.41× |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $9.4B | — | ||
| Q4 25 | $29.4B | $159.6M | ||
| Q3 25 | $23.0B | $164.1M | ||
| Q2 25 | $23.0B | $154.7M | ||
| Q1 25 | $23.7B | $346.2M | ||
| Q4 24 | $26.3B | $367.0M | ||
| Q3 24 | $10.5B | $362.0M | ||
| Q2 24 | $12.6B | $355.1M |
| Q1 26 | $44.4B | — | ||
| Q4 25 | $45.6B | $341.9M | ||
| Q3 25 | $44.6B | — | ||
| Q2 25 | $44.6B | — | ||
| Q1 25 | $45.7B | — | ||
| Q4 24 | $52.6B | $541.1M | ||
| Q3 24 | $53.2B | — | ||
| Q2 24 | $53.2B | — |
| Q1 26 | $6.0B | — | ||
| Q4 25 | $5.5B | $836.6M | ||
| Q3 25 | $-8.3B | $838.3M | ||
| Q2 25 | $-3.3B | $854.0M | ||
| Q1 25 | $-3.3B | $888.3M | ||
| Q4 24 | $-3.9B | $902.3M | ||
| Q3 24 | $-23.6B | $908.2M | ||
| Q2 24 | $-18.0B | $915.9M |
| Q1 26 | $164.8B | — | ||
| Q4 25 | $168.2B | $1.4B | ||
| Q3 25 | $150.0B | $1.4B | ||
| Q2 25 | $155.1B | $1.4B | ||
| Q1 25 | $156.5B | $1.6B | ||
| Q4 24 | $156.4B | $1.6B | ||
| Q3 24 | $137.7B | $1.6B | ||
| Q2 24 | $142.7B | $1.6B |
| Q1 26 | 7.41× | — | ||
| Q4 25 | 8.37× | 0.41× | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 0.60× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | — | $1.3M |
| Free Cash FlowOCF − Capex | $-1.5B | $-6.5M |
| FCF MarginFCF / Revenue | -6.5% | -3.4% |
| Capex IntensityCapex / Revenue | — | 4.1% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-1.0B | $-21.8M |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $1.3B | $1.3M | ||
| Q3 25 | $1.1B | $8.9M | ||
| Q2 25 | $227.0M | $20.3M | ||
| Q1 25 | $-1.6B | $-25.3M | ||
| Q4 24 | $-3.5B | $9.8M | ||
| Q3 24 | $-1.3B | $9.2M | ||
| Q2 24 | $-3.9B | $13.9M |
| Q1 26 | $-1.5B | — | ||
| Q4 25 | $375.0M | $-6.5M | ||
| Q3 25 | $238.0M | $570.0K | ||
| Q2 25 | $-200.0M | $14.0M | ||
| Q1 25 | $-2.3B | $-29.8M | ||
| Q4 24 | $-4.1B | $-1.8M | ||
| Q3 24 | $-2.0B | $-1.6M | ||
| Q2 24 | $-4.3B | $814.0K |
| Q1 26 | -6.5% | — | ||
| Q4 25 | 1.6% | -3.4% | ||
| Q3 25 | 1.0% | 0.3% | ||
| Q2 25 | -0.9% | 7.7% | ||
| Q1 25 | -11.7% | -17.8% | ||
| Q4 24 | -26.9% | -1.0% | ||
| Q3 24 | -11.0% | -0.9% | ||
| Q2 24 | -25.7% | 0.5% |
| Q1 26 | — | — | ||
| Q4 25 | 4.0% | 4.1% | ||
| Q3 25 | 3.8% | 4.4% | ||
| Q2 25 | 1.9% | 3.5% | ||
| Q1 25 | 3.5% | 2.7% | ||
| Q4 24 | 4.3% | 6.7% | ||
| Q3 24 | 3.4% | 6.4% | ||
| Q2 24 | 2.4% | 8.0% |
| Q1 26 | — | — | ||
| Q4 25 | 0.16× | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
BA
| Commercial Airplanes | $9.2B | 41% |
| Defense, Space & Security | $7.6B | 34% |
| Global Services | $5.4B | 24% |
NEO
| Client Direct Billing | $133.4M | 70% |
| Commercial Insurance | $31.4M | 17% |
| Medicare And Other Governmental | $25.4M | 13% |
